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ABSTRACT 
This paper reports on a generic packaging method for 
reducing drift in implantable pressure sensors. The described 
technique uses fluidic isolation by encasing the pressure 
sensor in a liquid-filled medical-grade polyurethane balloon; 
thus, isolating it from surrounding aqueous environment that 
is the major source of baseline drift. In-vitro tests using 
commercial micromachined piezoresistive pressure sensors 
show an average baseline drift of 0.006 cmH2O/day (0.13 
mmHg/month) for over 100 days of saline soak test, as 
compared to 0.101 cmH2O/day (2.23 mmHg/month) for a 
non-fluidic-isolated one soaked for 18 days. To our 
knowledge, this is the lowest reported drift for an implantable 
pressure sensor. 
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INTRODUCTION 
Pressure in various body organs, such as brain, heart, 
eyes, bladder, and gastrointestinal tract carries important 
diagnostic and prognostic information [1], [2].   Since the 
1950s, researchers and clinicians have developed numerous 
implantable wireless sensors to monitor a variety of clinically 
relevant pressures [3]. The first implantable pressure sensing 
device was an FM-modulated RF oscillator coupled to a 
ferrite-based pressure sensor [4]. More recently, with 
advances in microelectromechanical system (MEMS) 
sensors, wireless communication, high-density energy 
sources, the implantable pressure sensing systems have 
become more sophisticated [5]–[8]. However, due to baseline 
and sensitivity drifts, accurate long-term pressure monitoring 
is difficult to attain. These drifts are typically due to the 
exposure of the sensor to the aqueous environment. This 
results in the absorption of water into various polymeric 
materials used in the sensor package, cause swelling and 
generation of stress that is subsequently transmitted to the 
sensing element. Other sources of drift include changes in 
mechanical properties of the sensing elements due to aging, 
variations in the pressure of the reference cavity, corrosion 
and changes in the elastic modulus of the diaphragm resulted 
from adsorption of biomolecules, cells, and other debris [9]. 
The current solution for sensor drift includes a periodic 
recalibration. However, this is not an ideal approach for 
implantable devices since it frequently requires invasive 
procedures. Other solutions reported by several group uses 
custom made devices based on careful package design [5], 
[10], [11] avoiding any polymeric material in the construction 
and packaging. This naturally results in high costs and in-
house know-how, preventing the larger clinical and research 
communities from access to such systems. In this paper, we 
report a low cost and generic solution by isolating the sensor 
in an incompressible fluid-filled balloon. Performance of 
several fabricated prototypes were validated in aqueous 
environments. 
PACKAGNE STRUCTURE AND DESIGN 
Figure 1 shows a schematic view of the described sensor 
packaging method. The basic design of the implantable 
system can consist of the packaged pressure sensor and the 
main circuitry that handles signal and wireless 
communication. The two components are connected through 
a thin flexible cable. The advantage of such design is such 
that the sensor can be positioned near the pressure source, 
maintaining a small form factor, while the main circuitry can 
be implanted subcutaneously to increase the wireless link 
performance with moderate restrictions on size. In this paper, 
however, we focus on the sensor packaging. The combination 
of the packaging method with a readout and wireless interface 
can be found at our previous reports [12]. 
Figure 1: Schematic view of the pressure sensor package 
structure with fluidic isolation for baseline drift reduction. 
The fluidic-isolation packaging technique for the low-
drift implantable pressure sensor involves the encapsulation 
of the sensor along with the flexible interconnection cable in 
a medical-grade thin polyurethane balloon that is filled with 
a biocompatible incompressible liquid. The liquid must also 
be non-aqueous and non-polar to minimize its interaction 
with the pressure sensor and its polymeric packaging material 
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(e.g. parylene coating and epoxy used to cover wire bonds). 
In our case, we used silicone oil which in biocompatible and 
fulfills these requirements. While the medical-grade balloon 
isolate the pressure sensor from environmental drift causing 
factors, it also transfers pressure information without 
sacrificing the sensitivity.  
 
FABRICATION 
Figure 2 depicts the fabrication procedure for the generic 
fluidic-isolation sensor packaging technique. The packaging 
can be used with any conventional diaphragm-based pressure 
sensors. In our case, we used a commercial piezoresistive 
pressure sensor (Measurement specialties, MS5637-
02BA03), Figure 2a. The dimensions of the pressure sensor 
is 3 x 3 x 0.9 mm3, small enough to be adapt for many medical 
applications. Figure 2b illustrates the pressure sensor being 
mounted and connected to the main circuitry via a custom-
made polyimide flexible cable. The sensor and cable are then 
coated with Parylene-C for passivation. It is important to 
design the cable to have a certain length at both the distal and 
the proximal ends for full encapsulation by the balloon. The 
medical-grade balloon (Vention Medical, 06001000CA) in 
then inserted to encase the sensor and flexible cable, Figure 
2c. The overall size of the balloon used in our experiments 
was 10-mm length, 6-mm diameter, and 2.5-mm 
proximal/distal diameter. The balloon wall thickness was 30 
µm, thin enough to transfer the pressure without degrading 
the sensitivity and reliability.  
 
 
 
Figure 2: Packaging procedure starts with (a) pressure 
sensor (b) mounted on a flex-cable, (c) encapsulated with 
medical grades balloon and sealed at proximal end, (d) filled 
with incompressible fluid, (e) the balloon sealed at the distal-
end. 
 
The next step involves sealing the proximal end of the 
balloon (cable side) using a UV-curable acrylated urethane 
adhesive (Loctite, 3105 cured under a UV lamp, 
100mW/cm2, for 5 minutes). The UV-curable adhesives offer 
a tight leak-proof sealing on polyurethane medical-grade 
balloons [13]. While the sensor and cable are hold upright, an 
incompressible fluid such as silicone oil (Sigma-Aldrich, 
Dow Corning 200 fluid) is filled from the distal end, follow 
by dispensing a small amount of UV-curable adhesive, Figure 
2d. Since the density of UV-curable adhesive is less than 
silicone oil, it forms a thin layer on the top, Figure 2e. Figure 
3 shows the prototype of a fabricated device using the generic 
fluid-isolation sensor packaging technique.  
 
 
 
Figure 3: Optical photograph of a packaged sensor. 
 
EXPERIMENTAL RESULTS 
The packaged pressure sensor was evaluated in vitro by 
comparing its readouts with: 1) another similar sensor 
without the liquid-filled balloon (i.e., parylene-coated sensor 
in direct contact to saline, Figure 2b) called un-packaged 
from here on, and 2: a standard reference pressure sensor, 
called reference from here on. Figure 4 illustrates the 
validation experimental setup. The packaged sensor was 
placed in a pressure chamber that was filled with saline 
solution. The pressure chamber was then connected to a 
syringe pump and a commercial in-line pressure gauge 
(reference) (Omega DPG4000).  
 
 
 
Figure 4: Pressure sensor experiment setup; a syringe pump 
applied various pressures that is simultaneously monitored 
by the in-line commercial pressure gauge. 
 
Figure 5a shows the pressure measurements for the 
packaged and reference sensors (calibration test). As can be 
seen, the packaged sensor output matches with the reference 
in both pressure level and response time. Figure 5b shows 
concurrent agreements of pressure measurements for two 
systems, indicating a strong correlation of linear regression 
(R2 = 0.98, slope of 1.06 ± 0.01).  
 
 
 
Figure 5: (a) Pressure measurements comparing the 
packaged and reference sensors, (b) Linear regression 
showing pressure measured by the balloon-packaged sensor 
and the reference sensor. 
 
After validation/calibration tests, long-term baseline 
drift was investigated. The packaged pressure sensor was 
soaked in saline solution at room temperature (measuring 
daily atmospheric pressure changes) and its output was 
compared against the reference sensor. For control group, an 
unpackaged pressure sensor (Figure 2b) was prepared and 
soaked in saline. The packaged and unpackaged sensors were 
monitored for 100 days and 18 days, respectively. The 
baseline pressure measurement of packaged and unpackaged 
sensors compared to the reference is shown in Figure 6.  
 
 
 
Figure 6: Long-term baseline stability of the packaged sensor 
using fluidic-isolation technique and the unpackaged sensor 
 
The baseline drift of the packaged pressure sensor 
showed a slight fluctuation (maximum of 2 cmH2O) during 
its first 30 days; however, it remained very stable for the 
remaining time period. The extrapolated baseline drift of the 
packaged sensor was 0.006 cmH2O/day (or 0.13 
mmHg/month). The unpackaged sensor showed significant 
baseline drift even in the short investigation period (18 days); 
extrapolated baseline drift was 0.101 cmH2O/day (or 2.23 
mmHg/month).  
We also performed statistical analysis to show the 
agreement between the packaged sensors as compared to the 
reference using the Bland-Altman method, Figure 7. This 
method finds the relationship between the new technique and 
a gold standard that measure the same parameter using 
graphical techniques and simple calculations [14]. A zero 
difference in pressure between the packaged and the 
reference sensor indicate absolutely no baseline drift. The 
results show a negligible drift between the packaged and the 
reference sensor over time; remaining within  -0.58 cmH2O 
for 100 days, Figure 7a. The major baseline drift of the 
unpackaged sensor was also evaluated using the Bland-
Altman method. The baseline of unpackaged sensor shifted 
by a maximum of -2.93 cmH2O after 18 days, Figure 7b.  
 
 
 
Figure 7: Comparison of two measurement methods analyzed 
using Bland-Altman limit of agreement. The pressure 
difference is compared as a function of mean pressure  
 
CONCLUSIONS 
In conclusion, we demonstrated a generic packaging 
technique that leads to an extremely low baseline drift for 
implantable pressure sensors. After validation experiments, 
long-term baseline drift was investigated for 100 days. 
Overall baseline drift was 0.006 cmH2O/day (0.13 
mmHg/month), while the control un-packaged sensors 
showed a drift of 0.101 cmH2O/day (2.23 mmHg/month). 
The statistical analysis, linear regression and Bland-Altman 
agreement test, confirmed such low baseline drifts. 
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